The Nebraska Center for Virology (NCV) faculty research challenging topics addressing problems of epidemic proportions facing mankind including AIDS and HIV replication and pathogenesis, herpesvirus latency and cancer, human papilloma virus and cancers, and chlorellavirus biology. Our goals include designing novel vaccines and therapeutic strategies to block disease.
Each year, NCV invites applications for our Undergraduate Summer Research Experience in Virology (USREV) program from students enrolled at institutions in Nebraska as well as other states, who are motivated to explore the exciting opportunities for careers as scientists in biomedical research, while working with our experienced research faculty along side current graduate students and postdoctoral research associates in their labs.
As a selected student, you will design and implement a tailor-made research project. You will then conduct exciting and challenging experiments to test hypotheses under the guidance and mentoring of our expert faculty. As you are being trained in biomedical research, you will have the opportunity to explore cutting edge techniques and gain knowledge of the latest instrumentation by utilizing the equipment in our labs and the core facilities that provide support to our entire NCV faculty.
You will gain experience by learning how to conduct research and from many additional rewarding, enjoyable opportunities for our students including social and recreational activities, and cultural events, as well as self-help seminars that will prepare you in all aspects of graduate school life and beyond including resume writing, graduate school applications, test taking, grant writing and more.
Competitive stipend: $4,700
Suite-style room and meal plan
Travel expenses to and from Lincoln
Campus parking and/or bus pass
Full access to the Campus Recreation Center and campus library system
Research Interests: Dr. Angeletti’s research is focused on topics relating to sexually transmitted Human papillomaviruses (HPVs). The first topic involves the analysis of cis and trans-acting signals required for stable replication of HPVs. A second topic of interest is the analysis of the packaging requirements for HPVs. More recently, Dr. Angeletti has begun cervical cancer screening studies in Tanzania, which is funded by the National Cancer Institute (NCI). Another area of study is the role of HPV in ocular surface squamous neoplasm (OSSN) in the sub-Saharan African country of Zambia. In these studies, Angeletti looks at the affect of HIV upon formation of HPV-related neoplasms.
Dr. Deborah Brown
Nebraska Center for Virology
Development of influenza vaccines that promote cross protection and induce T cell memory responses to conserved antigens
Research Interests: Our research project is focused on the host immune response to viral infections. Primarily, we use mouse models of influenza infection to understand how CD4 T cells are activated during infection and the mechanisms employed by these cells to help clear infectious virus. We also use a T cell receptor (TCR) transgenic (Tg) mouse model in which all of the CD4 T cells recognize a piece of the influenza virus and various "knock-out" mouse strains lacking important immune response genes to determine which type of CD4 T cells provide protection to lethal influenza infections which will further our understanding of CD4 T cell biology and provide a framework for developing oval vaccine formulations to combat highly pathogenic and emerging influenza virus strains.
Plant-virus interactions, anti-viral RNA silencing, RNA virus replication and their interconnections
Hernan is a virologist interested in the molecular mechanisms of viral RNA replication and in antiviral RNA silencing. Hernan comes to UNL from the Donald Danforth Plant Science Center, where he was a research scientist. Hernan completed his postdoctoral work at the Oregon State University Center for Genomics and Biocomputing, with support from a Helen Hay Whitney fellowship. At UNL Hernan is the State Virologist and will teach a Molecular Virology class. Initial research will focus on the interconnection between RNA replication and RNA silencing mechanisms in viruses using yeast and plants as model systems in combination with genomic and bioinformatics approaches.
Understanding of the interaction of HIV-1 with its host during mucosal transmission, and development of anti-viral topical microbicide and vaccine
Research Interests: Qingsheng’s research focuses on better understanding the interaction of human immunodeficiency virus type-1 (HIV-1) with its host in the earliest infection to elucidate key steps and critical events in the mucosal transmission of HIV-1, to identify correlates of protection, and ultimately to develop an effective anti-viral topical microbicide and vaccine.
Tropism, immunopathogenesis, and vaccinology of porcine reproductive and respiratory syndrome virus (PRRSV) a major pathogen of swine
My research centers on pathogenesis of and immune response to viral infections. Due to the significance of the subject for U.S. animal agriculture, we focus on a major viral agent that affects swine: Porcine Reproductive and Respiratory Syndrome Virus (PRRSV, an arterivirus, ssRNA+ genome).
Replication and pathogenic mechanisms of RNA viruses
Studies in my laboratory focus on molecular biology and immunopathogenesis of two different viral pathogens, the vesicular stomatitis virus (VSV), a non-segmented negative-strand RNA virus in the family Rhabdoviridae and order Mononagavirales, and the porcine reproductive and respiratory syndrome virus (PRRSV), a positive-strand RNA virus in the family Arteriviridae and order Nidovirales. VSV has served as an excellent paradigm for many negative-strand RNA viruses (some of which are important human pathogens, such as respiratory syncytial, rabies, measles, and parainfluenza, hemorrhagic bunya and arenaviruses) to understand the basic mechanisms of the genetic expression of this group of viruses. PRRSV is an economically important pathogen, causing serious diseases in swine worldwide. Understanding the mechanism(s) of gene expression and its regulation as well as pathogenesis is essential for identifying virus-specific targets for therapeutic intervention in controlling infection by these viruses.
Role of IRF-3 in pathogenesis, as well as innate and adaptive immunity during Theiler’s Virus infection
All humans are infected with viruses throughout their lifetime. While most of these virus infections stimulate innate and adaptive immunity and are eliminated, it is estimated that each human is infected by 8-10 viruses that persistently stimulate the immune systems and are never eliminated. It is hypothesized that in some cases these persistent viral infections lead to diseases, such as Multiple Sclerosis (MS). As a model for persistent viral infections, his laboratory is focusing upon the innate immune response to the Theiler's Murine Encephalomyelitis Virus (TMEV). In some strains of mice, TMEV persistently infects macrophages of the immune system but is never eliminated within the lifetime of the individual mouse. Those mice strains end up with demyelination and symptoms like MS. In other strains of mice, TMEV is eliminated within a few weeks. However, the immune response to eliminate the virus is not without consequence and these mice end up with damage to the hippocampus region of the brain. We showed that failures within the innate immune system are causes of TMEV persistence but also protect the mice from immune mediated damage to host tissues.
The innate immune response to viral infection depends on Interferon Response Factor-3 (IRF-3), which plays a key role in induction of Type I interferons (IFN-alpha/beta), IL-6, and IL-12. We showed that IL-6 induces activation of STAT1 and ERK and thus is a key antiviral cytokine during this response to TMEV. We hypothesize that robust activation of IRF3 induces a high level of IL-6 expression that contributes to viral control but also causes damage to the hippocampus. We have shown that functional IRF3 is related to viral clearance but is also related to hippocampal damage. In addition to innate cytokine production, IRF-3 is also involved in the induction of apoptosis (programmed cell death) that is triggered in virus-infected cells. Apoptosis prevents viral persistence and infection into surrounding cells. We have also found that IRF-3 of mice that cannot eliminate TMEV differs from IRF-3 of mice that can control this virus, in that it cannot participate in virus induced apoptosis as well. Therefore our central hypothesis is that differences in host IRF-3 underlie persistent infections with certain viruses but also immune mediate damage during viral infections.
Cellular and molecular mechanisms of auto-immunity
Most healthy individuals have a propensity to develop autoimmune diseases, as evidenced by the presence of autoreactive T cells in their naïve periphery. T cells are educated in the thymus, where high-affinity T cell receptor (TCR)-bearing cells that interact with self-antigens are deleted by negative selection, while T cells with low-affinity TCR to self-antigens are selected positively and exported to the periphery. In spite of the presence of self-reactive T cells in the naïve peripheral repertoires, autoimmune responses do not ensue spontaneously. How this tolerance is maintained is a fundamental question. It has been suggested that the environmental antigens that bear similarities to self-antigens break self-tolerance by cross-reactivity. To this end, we focus our investigations on the identification of microbial products that can potentially induce autoimmunity in the heart and immunologically privileged sites such as the central nervous system and eyes through antigenic mimicry. Mechanistically, we are particularly interested in delineating the role of antigen-specific T cells in the autoimmune diseases of infectious origin.
Characterization of large dsDNA viruses that infect certain chlorella-like green algae
Research in the Van Etten laboratory focuses on the isolation and characterization of large icosahedral, dsDNA-containing, plaque-forming viruses that infect certain unicellular, eukaryotic chlorella-like green algae. These viruses are ubiquitous in fresh water from all over the world. The chlorella viruses have genomes as large as 370 kb that contain as many as 400 protein encoding- and 16 tRNA encoding-genes. Besides their large genomes, the chlorella viruses have other unexpected features: (i) They encode multiple DNA methyltransferases and DNA restriction endonucleases. (ii) Unlike other glycoprotein-containing viruses, chlorella viruses encode most, if not all, of the components required to glycosylate their proteins. (iii) Many chlorella virus-encoded proteins are either the smallest or among the smallest proteins of their class. Consequently, these proteins serve as models for mechanistic and structural studies. Infection by the chlorella viruses resembles bacterial infection by tailed bacteriophages in many respects.
Immune response against porcine respiratory and reproductive syndrome virus (PRRSV), and development of vaccines
My laboratory studies two important viruses of swine: porcine reproductive and respiratory syndrome virus (PRRSV) and influenza A virus of swine (IAV-S). The research topics that are studied in my laboratory include: (i) Host immune responses to natural infection or vaccination, (ii) Molecular characteristics of the viruses currently circulating in the swine population, and (iii) Viral proteins and/or epitopes capable of eliciting protective immunity. Collectively, results obtained from these studies will be valuable for the optimal design safe and effective vaccines against divergent viral strains circulating in the field.
Adenovirus vector for vaccine against influenza and other viruses
My current research explores the use of bioinformatics, phylogenetics, immunology and molecular biology to study the basic mechanisms of host-pathogen interactions and to create improved vaccines against microbial diseases. My research program can be broken into two arms, vaccine antigen design and vaccine platform design. First, we are testing ancestral/centralized genes to determine if they are useful as universal vaccines in vivo. In addition we are exploring systems biology approaches to improve vaccine antigen design to improve the breadth and efficacy of the vaccine antigens. Second, vaccine platform design explores the use of alternative viral vectors as vaccines, as well as the development of safer more effective viral vaccine platforms.
Understanding intracellular defenses against foreign DNA by using poxvirus-infected cell models
One of the most fundamental questions in the field of immunology is how our immune system identifies an invading pathogen as “foreign” rather than “self”. When this decision is made correctly growth of the virus or bacteria can kept at a minimum. However, failure to recognize an invader extends the amount of damage it may produce or, if self is incorrectly regarded as foreign, then autoimmune disease occurs. While significant progress has been made toward identifying viral and bacterial components which are found to be “foreign” and activate the immune system, much remains to be learned.
HIV and Kaposi’s sarcoma associated human herpesvirus transmission, evolution, and disease pathogenesis
Research Interests: The Wood laboratory focuses on HIV/AIDS and AIDS associated cancers in Africa. The lab studies the transmission and evolution of HIV, and the risk factors that are involved. Research involves collaboration with University Teaching Hospital in Zambia and the Ocean Road Cancer Institute in Tanzania, countries in Africa where HIV/AIDS and AIDS associated cancers such as Kaposi’s sarcoma (KS) are prevalent. They study neuroAIDS and whether the brain can serve as an HIV reservoir, how HIV is transmitted from mothers to their infants, and how the virus evolves into new strains to develop drug resistance in infected individuals in Zambia. A parallel project is to study the transmission of a human herpesvirus, known as the Kaposi’s sarcoma virus in both Zambia and Tanzania, which is linked to KS in AIDS patients. The focus is to determine how frequent is the infection by this virus, its route of transmission, the mechanism that this viruses causes cancer and how HIV acts as a co-factor, especially in AIDS patients.
HIV envelope glycoprotein structure, function, vaccine design, and utilizing commensal bacteria for anti-HIV infection
Human immunodeficiency virus type 1 (HIV-1) is the etiologic agent of AIDS (Acquired Immune Deficiency Syndrome). About thirty years after identification of HIV as the causative agent of AIDS, the AIDS epidemic remains a global health issue. Our research interests are focused on HIV/AIDS, with the ultimate goal of developing an effective vaccine or a long-term preventive strategy to counter this devastating pandemic. In addition, we are also working on small ruminant lentviruses (SRLV) and try to find the genetic resistant-forms against SRLV infection.
The current major projects in our laboratory are described below.
I. Envelope Structure and Viral Entry
Human immunodeficiency virus type 1 (HIV-1) is the etiologic agent of AIDS (Acquired Immune Deficiency Syndrome). About thirty years after the identification of HIV as the causative agent of AIDS, the AIDS epidemic remains a global health issue. Our research interests are focused on HIV/AIDS, with the ultimate goal of developing an effective vaccine or a long-term preventive strategy to counter this devastating pandemic. In addition, we are also working on small ruminant lentiviruses (SRLV) and try to find the genetic resistant-forms against SRLV infection. The current major projects in our laboratory are described below.
I. Envelope Structure and Viral Entry
HIV-1 is an enveloped virus, requiring for cell entry a membrane fusion process mediated by the interactions of viral envelope glycoproteins (gp120 and gp41), a primary receptor CD4, and a chemokine coreceptor (CCR5 or CXCR4). Viral entry is a critical step for establishing infection, thus providing a powerful incentive to understand the intricate biochemical mechanisms of viral entry as a prerequisite for developing effective antiviral therapies. The interaction of HIV-1 gp120 and the CD4 receptor has been well characterized. However, the interactions between viral envelope glycoproteins and the HIV co-receptor (CCR5 or CXCR4) are poorly understood. For example, it is not clear how the HIV gp120 core and V3 loop contact the N-terminal and extracellular loops of CCR5 to facilitate the entry process, nor has the molecular structure of CCR5 been elucidated. We will investigate the interactions between gp120 and the coreceptor CCR5 or CXCR4, employing various molecular and cellular approaches to dissect these associations in more detail.
II. Envelope-Based AIDS Vaccine Development
The HIV-1 envelope has evolved such an immunosuppressive state that does not provoke adequate immunogenicity to trigger the production of neutralizing antibodies. Therefore, our research objective is to improve the immunogenicity of the HIV-1 envelope. The approach involves stabilizing a CD4-bound conformation of gp120, in which CD4 as well as the co-receptor (CCR5 or CXCR4) binding sites are exposed. These two sites are the most conserved regions in the HIV-1 Env. This gp120 antigenic conformation should induce a much stronger immune response, and consequently, elicit more potent neutralizing antibodies.
Another approach involves epitope-based antigen design. Epitope information gleaned from studies of known neutralizing antibodies such as VRC01, b12 or 2G12 should facilitate fragment structure-based design. We anticipate that a small epitope might elicit potent neutralizing antibodies against the virus.
Dr. Luwen Zhang
School of Biological Sciences
Herpesvirus-host interactions in innate immunity and cancer formation
Research Interests: Dr. Luwen Zhang’s laboratory studies the transformation processes. Epstein-Barr virus is (EBV) a human herpesvirus of increasing medical importance. EBV infection has been associated with the development of several human cancers. In immunocompromised individuals, such as organ transplant recipients or AIDS patients, EBV almost certainly causes two fatal cancers: post-transplantation lymphoproliferative disorder (PTLD) and AIDS-associated central nerve system (CNS) lymphoma. The Zhang lab tackles the problems related to how virus interacts with cell, and transforms normal cells into cancerous ones. Also, potential treatment of human cancers is also on their agenda. Zhang lab has been testing a novel approach to specifically block the viral transformation events that lead to the development of human cancers.